SMITH WAYNE T. - 21 Feb 2025 Form 4 Insider Report for COMMUNITY HEALTH SYSTEMS INC (CYH)

Role
Director
Signature
Christopher G. Cobb, Attorney in Fact for Wayne T. Smith
Issuer symbol
CYH
Transactions as of
21 Feb 2025
Net transactions value
$0
Form type
4
Filing time
21 Feb 2025, 17:59:39 UTC
Previous filing
01 Mar 2024
Next filing
03 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYH Common Stock Gift $0 -20,336 -0.39% $0.000000 5,206,739 21 Feb 2025 Direct F1
holding CYH Common Stock 1,606,842 21 Feb 2025 by The Modified 2009 WTS Irrev Trust Dated 12/16/22
holding CYH Common Stock 481,721 21 Feb 2025 WAC LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYH Performance Based Restricted 180,000 21 Feb 2025 Common Stock 180,000 $0.000000 Direct F2
holding CYH Restricted Stock Units 227,409 21 Feb 2025 Common Stock 227,409 $0.000000 Direct F3
holding CYH Stock Options (Right to Buy) 78,750 21 Feb 2025 Common Stock 78,750 $4.99 Direct
holding CYH Stock Options (Right to Buy) 112,500 21 Feb 2025 Common Stock 112,500 $4.93 Direct
holding CYH Stock Options (Right to Buy) 90,000 21 Feb 2025 Common Stock 90,000 $8.81 Direct
holding CYH Stock Options (Right to Buy) 90,000 21 Feb 2025 Common Stock 90,000 $10.18 Direct F4
holding CYH Stock Units (SU) 35,609 21 Feb 2025 Common Stock 35,609 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were gifted to individuals who do not share the Reporting Person's household.
F2 The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
F3 These restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral elections pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.
F4 Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
F5 The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person.